Radioterapia no Câncer do Nasofaringe
DOI:
https://doi.org/10.32635/2176-9745.RBC.1954v11n12.4176Keywords:
Nasopharyngeal Neoplasms/radiotherapy, Nasopharyngeal Neoplasms/epidemiology, Nasopharyngeal Neoplasms/therapyAbstract
Our experience with câncer of the nasopharynx is concerned with 87 cases examined and treated from 1939 to 1954. They were all confirmed by biopsy directly made from the nasopharynx. In this paper only 37 of the patients are considered, 33 of them belonging to the National Câncer Service and 4 from my private practice. They were seen during the period from 1939 to 1949, therefore having finished treatment for at least 5 years ago. The distribution of the cases according to the histological examination is the following: Transitional cell carcinoma: 20 cases, Squamous cell carcinoma: 11 cases, Reticulosarcoma: 3 cases, Lymphosarcoma: 3 cases. In all cases a radiological study of the nasopharynx, was made routinely with X-rays taken in lateral, Hirtz, fronto-nasal and mento-nasal positions being made. Radiological examination was of great value not only as a diagnostic means but also to show the frequent invasion of the base of the skull and also as a means of follow-up control. In our cases, 15 (40%) showed bone invasion at the base of the skull. Relation of cranial nerve invasion and bone destruction of the base of the skull was studied. Ten (27%) of our cases showed cranial nerve involvement. Câncer of the nasopharynx was treated exclusively by irradiation. Surgery was not employed for the following 3 reasons: 1rt) Difficult approach. 2nd) — Frequent bone invasion at the base of the skull which would made total extirpation impossible. 3d) — Most of the tumors are of the anaplastic type with distant lymph gland involvement. Treatment consisted exclusively in roentgentherapy, radium being also done associated by in 3 cases. Radiotherapy was done by the fractionated method, and the duration of treatment varied from 6 to 12 weeks. Physical factors were the following: kilovoltage varied from 200 to 400 Kv. Filtration was always 1.0mm. Cu. and the half value layer varied from 1.5 to 3.0mm. of Cu. The tumor dose varied from 3,000 to 6,000r. In all cases 4 fields were routinely given (2 lateral traszigomatical and 2 infra-orbitrarial). To treat the cervical node metastasis other fields were employed, always according to the size of the tumors. Six of the 37 cases were not treated due to their great advancement with lymph node, visceral and boné invasion. Five (167c) of the 31 cases treated, survived 5 and more years with no symptoms of cancer.
Downloads
References
LACK, H.L. — The diseascs of the nose and throat and its acessory sinuses, London, Longpnans, Green & Co. 1906.
MARTIN, H.E. o BLADY, J.V. — Câncer of the nasopharynx. Arch. Otolaryng., 1940, 32, 692-727. DOI: https://doi.org/10.1001/archotol.1940.00660020697006
BACLESSE, F. e DULAC, C. — Les tumeurs malignes du rhinopharynx. Bull. Assoe, franç. p. Tetude du câncer. 31: 160-177, 1943.
SIMMONS, M.W. e ARIEL, I.M. — Carcinoma of Nasopharynx. Surg. Gynec. and Obst. 88, 763-775, June 1949.
MILLER, D. — Nasopharyngeal Câncer — The Laryngoscope, Vol. LXI, March 1951, n." 3, 187-214. DOI: https://doi.org/10.1288/00005537-195103000-00001
DIGBY, K. H.; THOMAS, G.H. e TSE, H.S. — Notes on Carcinoma of the Nasopharynx. Caduceus 1930: Vol. 9 n.° 2.
MARTIN, H. e QUAN, S. — The Radical Incidence (Chinese) of Nasopharyngeal Câncer. Ann. Otol. Rhin. & Laryng. 60: 168-174. March. 1951. DOI: https://doi.org/10.1177/000348945106000113
EWING, J. — Neoplastic Diseascs. 1938.
MORRISON, L.R.; HOPP, E.S. e WU, R. — Diagnosis of malignancy of the Nasopharynx. Citological Studies by the Smear Technique. Ann. Otol. Rhinol. and Laryng. 58: 18 Mar. 1949. DOI: https://doi.org/10.1177/000348944905800102
FRIEDMANN, I. — Exfoliative Citology as an Aid in the Diagnosis of Tumours of the Throat, Nose and Ear. J. Laryng. & Otol. 65: 1-9 (Jan.) 1951. DOI: https://doi.org/10.1017/S0022215100009683
RUBENFELD, S.E. WINSTON, R. — Diagnosis of tumours of the Nasopharynx by citological procedure A.M.A. Archives of Otolaryngology, April 1953 _Vol. 57 n." 4 pag. 442-449. DOI: https://doi.org/10.1001/archotol.1953.00710030463009
NEW, G.B. — Highly malignant tumors of the nasopharynx and pharynx. Jour. Amer. Acad. Ophth. and Otolaryng. 36-39. 1931.
FURSTENBERG, A. C. — Malignant Neoplasms of the Nasopharynx Surg. Gynec. and Obst., 66: 400-404. Feb. 1938.
KASABACK, H. H. — Symposium on Nasopharyngeal Tumors. The Laryngoscope 31: 459-463. May 1941. DOI: https://doi.org/10.1288/00005537-194105000-00007
VIEIRA, A. PINTO e MACHADO NETO, E. — Radiologia dos tumores malignos do rinoaringe. Actas del Tercer Congreso Inter-Americano de Radiologia. Pg. 480-491. 1949.
REVERCHON — Deux cas de tumeur du rhinopharynx Bull. d’otorhino-laryngol., 1922, 20, 245.
COLLET e REBATTU — Étude sur la propagation intracrânienne des tumeurs du pharynx. Arch. internat. de laryngol. 1923, 29, 945-953.
GAILLARD, R. — À propos des tumeurs du pharynx nasal à point de départ péri-tubulaire. Ann. d. mal. d. Toreille du pharynx (etc.) 1923, 42, 772-780.
MARTIN, L.C. — Complications produced by malignant tumors of the nasopharinx. Am. J. Roentgenol. & Rad. Therapy., 1939, 41, 377-390.
CAMINHA, N.C. — A radiologia nos tumores malignos do Rinofaringe. 1943.
BAZZANA, E. — I tumori maligni del rinofaringe. Oto-rinolaring. ital. 6: 319, 1936.
NEEDLES, W. — Malignant tumours of the nasopharynx. J. Nerv. Ment. Dis. 86: 373. 1937. DOI: https://doi.org/10.1097/00005053-193710000-00001
LENZ. M. — Roentgentherapy of primary Câncer of the Nasopharynx. Am. J. Roentgenol. & Rad. Therapy. Vol. XLVIII, n.° 6, Dec. 1942.
NEW, G.D. e STEVENSON, W. — End-Results of treatment of Malignant lesions of the nasopharynx. Arch. Otolaryng. 38: 206-209. Sept. 1943. DOI: https://doi.org/10.1001/archotol.1943.00670040218001
Downloads
Published
How to Cite
Issue
Section
License
Os direitos morais e intelectuais dos artigos pertencem aos respectivos autores, que concedem à RBC o direito de publicação.
This work is licensed under a Creative Commons Attribution 4.0 International License.